Lesson 20 Flashcards
what does CAR-T stand for?
CAR stands for chimeric antigen receptor, a synthetic receptor that is expressed after engineering T lymphocytes
what is the function of CAR-T?
is able to reprogram T lymphocytes to kill tumor cells after the recognition of specific target antigens on their surface
what is the most diffuse antigen targeted by CAR-T cells?
CD19 - a protein expressed in the vast majority of leukemia and lymphomas
how does the immune system fail in cancer?
the immune system and in particular T lymphocytes, responsible for the cytotoxic activity, fail to recognize
malignant cells
how fast do cells become malignant?
they need several mutations
what is the aim of immunotherapy?
to boost the immune system of the patients and make T lymphocytes able to recognize malignant cells
once T lymphocytes are collected from a patient, how can they be altered?
they can be engineered using gene transfer techniques to induce the expression on T lymphocytes of the chimeric antigen receptor
why is the chimeric antigen receptor unique?
it can recognize only the malignant cells and not normal ones
what occurs after these engineered antigen receptors are re-infused into the patient?
since the T lymphocytes are cytotoxic, they can destroy malignant cells thanks to the fact that the CAR-T cels have a high specificity for antigens present on malignant cells
what is one of the most important steps in CAR-T production?
the isolation of specific antigens expressed on malignant cells in order to design the chimeric receptor → otherwise CAR-T will act against healthy tissues as well
what was a problem that occurred during the production of CAR-T cells in terms of their expression?
If a new T cell receptor (TCR) is introduced in T lymphocytes, the resulting CAR-T cell will display the new chimeric antigen, but also the expression of the endogenous TCR →there will be competition between the new and the endogenous receptor
how is gene editing used to fix the TCR gene problem in the production of CAR-T cells?
KO of the endogenous TCR gene
describe the editing process to KO the endogenous TCR gene:
editing, we need a specific guide for the endogenous TCR genes, TCRa and TCRb, and Cas9. After disrupting the endogenous TCR locus, we can introduce the new CAR by viral vector nanoparticles or any other technique efficient for the transfer in T lymphocytes
what is another important application of gene editing and KO in cancer therapy?
the knock out of PD-1
how can T-lymphocytes interact with PD-1?
tumor expresses PD-L1 (the ligand for PD-1) present on the surface of the T
lymphocyte, so the tumor cell can interact with a T lymphocyte through PD-1
what is PD-1?
one of the so-called immune checkpoint molecules → after the interaction with the ligand, this molecule gets activated and it represents one of the inhibitor signals for the cytotoxic activity of T lymphocytes.
what occurs if we are able to disrupt PD-1 in cytotoxic T lymphocytes using CRISPR/Cas9 and other genome editing techniques?
PD-L1 won’t be able to interact with the receptor PD-1 anymore, because this is will not expressed in T lymphocytes → prevents the escape of the tumor from the IS
what are some possible delivery methods for there transfer of editing machinery to a cell?
electroporation and nanoparticles